Literature DB >> 31903078

Is There a Prescription to Treat Pediatric Obesity?

Sneha Baxi Srivastava1.   

Abstract

Pediatric obesity is complex-in every way. The pathogenesis, which is a result of a multitude of factors combined with social and environmental factors makes it a crisis with overwhelming challenges. It is difficult to treat pediatric obesity; however, guidelines attempt to clarify how to approach treatment. These strategies are mostly interventions in lifestyle because only 1 medication is approved for treating obesity in children. The approach to the treatment of pediatric obesity will need to be a one that relies on the available data, a continued drive for additional research and publication, sharing of practice experience, and continued efforts at prevention.
© 2019 The Author(s).

Entities:  

Keywords:  lifestyle; metformin; nutrition; obesity; orlistat; overweight; pharmacology; phentermine; topiramate

Year:  2019        PMID: 31903078      PMCID: PMC6933557          DOI: 10.1177/1559827619881095

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  13 in total

Review 1.  Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach.

Authors:  Michael Freemark
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

2.  Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of Obesity and Severe Obesity in US Children, 1999-2016. Pediatrics. 2018;141(3):e20173459.

Authors: 
Journal:  Pediatrics       Date:  2018-09       Impact factor: 7.124

3.  Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association.

Authors:  Aaron S Kelly; Sarah E Barlow; Goutham Rao; Thomas H Inge; Laura L Hayman; Julia Steinberger; Elaine M Urbina; Linda J Ewing; Stephen R Daniels
Journal:  Circulation       Date:  2013-09-09       Impact factor: 29.690

4.  Prevalence of Obesity Among Adults and Youth: United States, 2015-2016.

Authors:  Craig M Hales; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden
Journal:  NCHS Data Brief       Date:  2017-10

5.  Liraglutide in Children and Adolescents with Type 2 Diabetes.

Authors:  William V Tamborlane; Margarita Barrientos-Pérez; Udi Fainberg; Helle Frimer-Larsen; Mona Hafez; Paula M Hale; Muhammad Y Jalaludin; Margarita Kovarenko; Ingrid Libman; Jane L Lynch; Paturi Rao; Naim Shehadeh; Serap Turan; Daniel Weghuber; Timothy Barrett
Journal:  N Engl J Med       Date:  2019-04-28       Impact factor: 91.245

Review 6.  Pharmacotherapy for childhood obesity: present and future prospects.

Authors:  R Sherafat-Kazemzadeh; S Z Yanovski; J A Yanovski
Journal:  Int J Obes (Lond)       Date:  2012-08-28       Impact factor: 5.095

Review 7.  Pediatric obesity pharmacotherapy: current state of the field, review of the literature and clinical trial considerations.

Authors:  A S Kelly; C K Fox; K D Rudser; A C Gross; J R Ryder
Journal:  Int J Obes (Lond)       Date:  2016-04-26       Impact factor: 5.095

Review 8.  Pediatric Obesity: Influence on Drug Dosing and Therapeutics.

Authors:  Barbara Ameer; Michael A Weintraub
Journal:  J Clin Pharmacol       Date:  2018-10       Impact factor: 3.126

9.  Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.

Authors:  Dennis M Styne; Silva A Arslanian; Ellen L Connor; Ismaa Sadaf Farooqi; M Hassan Murad; Janet H Silverstein; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

Review 10.  What use is the BMI?

Authors:  D M B Hall; T J Cole
Journal:  Arch Dis Child       Date:  2006-04       Impact factor: 3.791

View more
  1 in total

1.  Assessing the use of prescription drugs and dietary supplements in obese respondents in the National Health and Nutrition Examination Survey.

Authors:  Laura A Barrett; Aiwen Xing; Julia Sheffler; Elizabeth Steidley; Terrence J Adam; Rui Zhang; Zhe He
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.